Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415

PURPOSE: The Expanded Prostate Cancer Index Composite (EPIC) is the most commonly used patient reported outcome (PRO) tool in prostate cancer (PC) clinical trials, but health utilities associated with the different health states assessed with this tool are unknown, limiting our ability to perform co...

Descripción completa

Detalles Bibliográficos
Autores principales: Khairnar, Rahul, Pugh, Stephanie L., Sandler, Howard M., Lee, W. Robert, Villalonga Olives, Ester, Mullins, C. Daniel, Palumbo, Francis B., Bruner, Deborah W., Shaya, Fadia T., Bentzen, Soren M., Shah, Amit B., Malone, Shawn C., Michalski, Jeff M., Dayes, Ian S., Seaward, Samantha A., Albert, Michele, Currey, Adam D., Pisansky, Thomas M., Chen, Yuhchyau, Horwitz, Eric M., DeNittis, Albert S., Feng, Felix Y., Mishra, Mark V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046237/
https://www.ncbi.nlm.nih.gov/pubmed/33852571
http://dx.doi.org/10.1371/journal.pone.0249123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046237/
https://www.ncbi.nlm.nih.gov/pubmed/33852571
http://dx.doi.org/10.1371/journal.pone.0249123

Ejemplares similares